Wells Fargo Sees Amphastar Pharmaceuticals, Inc.’s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts.

The seventh banal among the small-cap stocks is Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH).

TheFly reported connected February 27 that Wells Fargo reduced its terms people connected AMPH to $30 from $34 and kept an Overweight standing connected the shares. Despite the caller approvals of AMP-015 and AMP-007, the steadfast observes that the banal is nether unit due to the fact that of the reduced income projection. According to the firm, AMP-007's show is anticipated to beryllium important successful attaining mid-to high-single-digit gross maturation successful the future.

In a caller development, the FDA approved Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)'s Abbreviated New Drug Application (ANDA) for Ipratropium Bromide HFA Inhalation Aerosol, 17 mcg per actuation, connected February 26. The FDA recovered that AMPH's merchandise is medically and bioequivalent to Atrovent HFA Inhalation Aerosol from Boehringer Ingelheim.

For this inhalation aerosol, AMPH is entitled to 180 days of generic exclusivity since it is the archetypal ANDA applicant to person a Paragraph IV certification. The archetypal time of the product's commercialized instauration volition people the commencement of this exclusivity period, giving AMPH a little model of marketplace protection.

In summation to supporting the company's Q4 2025 net report, the support is simply a large regulatory milestone that puts it successful a presumption to summation its marketplace stock successful the respiratory medicine manufacture portion utilizing the advantages of exclusivity to spur aboriginal merchandise uptake.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is simply a biopharmaceutical institution that develops, manufactures, and markets injectable, inhalation, and intranasal medications, including analyzable generics and proprietary products, for hospitals and objective use. Its portfolio addresses captious attraction needs and cause transportation innovations.

While we admit the imaginable of AMPH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best GARP Stocks to Buy According to Analysts and 14 Best Affordable Dividend Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey connected Google News.